Cannabis and tobacco co-use predicts psychosis in clinical high risk cohorts
Abstract Cannabis and tobacco use are highly prevalent among people with psychosis and are associated with medical comorbidities and poor…
Abstract Cannabis and tobacco use are highly prevalent among people with psychosis and are associated with medical comorbidities and poor…
Abstract Background: Despite the high and increasing rates of cannabis and nicotine/tobacco product (NTP) use during pregnancy, the impact of…
Abstract Background: Tobacco and cannabis are among the most widely used substances globally, and rates of co-use are on the…
Abstract Background: Approximately 30 % of people who use tobacco also use cannabis, and rates of co-use are rising. Relative…
Abstract Repetitive transcranial magnetic stimulation (rTMS) is a promising treatment for cannabis use disorder in schizophrenia; however, gaps in the…
Abstract Cannabis use disorder (CUD) occurs at high rates in schizophrenia, which negatively impacts its clinical prognosis. These patients have…